Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX
· Real-Time Price · USD
1.15
-0.01 (-0.43%)
At close: Aug 15, 2025, 12:29 PM
Rein Therapeutics Revenue
Rein Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Rein Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
11
Market Cap
26.49M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|